Outlook | Published:

Biology: A slow-motion epidemic

Nature volume 540, pages S98S99 (22 December 2016) | Download Citation

The symptoms of Crohn's disease and ulcerative colitis, the two main forms of inflammatory bowel disease (IBD), can be severe and lifelong. And the condition is becoming increasingly common worldwide.

The battle within

In general, IBD is thought to occur when the immune system overreacts to the bacterial community that normally dwells in the gut, setting in motion a chain of inflammation events that can damage and destroy the intestinal wall.

Image: Illustration by Lucy Reading-Ikkanda

Similar, yet different

Most cases of IBD are classified as either ulcerative colitis (UC) or Crohn’s disease (CD). The relative prevalence of these two conditions varies widely across different geographical regions (see chart).

Image: Illustration by Lucy Reading-Ikkanda

Between 5% and 15% of cases cannot immediately be put into either category and are instead referred to as ‘indeterminate colitis’. Despite sharing similar symptoms, there are important pathological distinctions between the two main forms of IBD.

Image: Illustration by Lucy Reading-Ikkanda

Nature and nurture

A variety of hereditary, environmental and lifestyle factors are thought to influence IBD pathology. However, researchers are still grappling with exactly how these elements individually and collectively affect the natural history of the disease.

Image: Illustration by Lucy Reading-Ikkanda

A growing global disease

IBD is most common in North America, Western and Northern Europe, Australia and New Zealand4. Cases are much less common in non-Western nations, but this is changing — incidence rates have climbed rapidly in recent years in parts of Asia and South America.

Image: Illustration by Lucy Reading-Ikkanda

Regional, local, individual

Beneath the global data lie smaller-scale trends that reveal the complex mix of factors that determine a person’s risk of disease.

Image: Illustration by Lucy Reading-Ikkanda

Image: Illustration by Lucy Reading-Ikkanda

Sources

  • 1. Molodecky, N. A. et al. Gastroenterology 142, 46–54 (2012).

  • 2. Ananthakrishnan, A. N. Nature Rev. Gastroenterol. Hepatol. 12, 205–217 (2015).

  • 3. Sartor, R. B. et al. Nature Clin. Prac. Gastroenterol. Hepatol. 3, 390–407 (2006).

  • 4. Kaplan, G. G. Nature Rev. Gastroenterol. Hepatol. 12, 720–727 (2015).

  • 5. Thia, K. T. et al. Am. J. Gastroenterol. 103, 3167–3182 (2008).

  • 6. Victoria, C. R. et al. Arq. Gastroenterol. 46, 20–25 (2009).

  • 7. Khalili, H. Gut 61, 1686–1692 (2012).

  • 8. Soon, I. S. et al. BMC Gastroenterol. 12, 51 (2012).

  • 9. Bernstein, C. N. et al. Am. J. Gastroenterol. 101, 993–1002 (2006).

About this article

Publication history

Published

DOI

https://doi.org/10.1038/540S98a

Authors

  1. Search for Michael Eisenstein in:

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing